Medtronic (MDT) Restructuring Costs (2014 - 2026)

Medtronic has disclosed Restructuring Costs across 13 years of filings, most recently posting -$138.0 million for Q2 2026.

• In Q2 2026, Restructuring Costs fell 184.66% year-over-year to -$138.0 million; the TTM figure through Jul 2026 stood at $47.0 million (down 83.33% YoY), while the FY2026 annual figure was $113.0 million, down 64.35% from the prior year.
• Restructuring Costs came in at -$138.0 million for Q2 2026 at Medtronic, down from $172.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $300.0 million in Q2 2023 to a low of -$138.0 million in Q2 2026.
• Average Restructuring Costs over 5 years is $96.4 million, with a median of $84.5 million recorded in 2022.
• The largest YoY upside for Restructuring Costs was 273.91% in 2026 against a maximum downside of 184.66% in 2026.
• Over 5 years, Restructuring Costs stood at $95.0 million in 2022, then slipped by 4.21% to $91.0 million in 2023, then sank by 49.45% to $46.0 million in 2024, then plunged by 71.74% to $13.0 million in 2025, then slumped by 1161.54% to -$138.0 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were -$138.0 million in Q2 2026, $172.0 million in Q1 2026, and $13.0 million in Q4 2025.